Gilead’s Covid-19 Drug is Mediocre. It Will Be a Blockbuster Anyway.

Gilead Sciences said Wednesday that remdesivir, which has been authorized for emergency use since the spring, brought in $873 million in revenues so far this year.

from NYT > Health https://ift.tt/31QSZsg

Comentarii

Postări populare de pe acest blog

The Best Food, Drink, and Home Service Subscriptions to Give as Wedding Gifts

The daily coronavirus update: Double-digit deaths for second day in a row; 82,716 total cases

6 Easy Mother’s Day Gifts for the Mom Who Says She Doesn’t Want Anything